|
|
Volumn 159, Issue 2, 2002, Pages 177-179
|
|
Atypical antipsychotic medications and the treatment of schizophrenia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOZAPINE;
HALOPERIDOL;
NEUROLEPTIC AGENT;
OLANZAPINE;
RISPERIDONE;
DRUG EFFICACY;
EDITORIAL;
EVIDENCE BASED MEDICINE;
HUMAN;
MEDICAL DECISION MAKING;
PATIENT SELECTION;
PRIORITY JOURNAL;
SCHIZOIDISM;
SCHIZOPHRENIA;
ANTIPSYCHOTIC AGENTS;
DOUBLE-BLIND METHOD;
HUMANS;
META-ANALYSIS;
PSYCHIATRIC STATUS RATING SCALES;
RANDOMIZED CONTROLLED TRIALS;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
SULPIRIDE;
TREATMENT OUTCOME;
|
|
EID: 0036163838
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.159.2.177 Document Type: Editorial |
|
Times cited : (13)
|
|
References (2)
|
